Psyence Group Inc. (PSYGF)
OTCMKTS · Delayed Price · Currency is USD
0.1165
+0.0185 (18.88%)
At close: Jun 25, 2025
Psyence Group Market Cap
Psyence Group has a market cap or net worth of $1.93 million as of August 1, 2025. Its market cap has decreased by -72.45% in one year.
Market Cap
1.93M
Enterprise Value
1.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since January 28, 2021, Psyence Group's market cap has decreased from 35.40M to 1.93M, a decrease of -94.56%. That is a compound annual growth rate of -47.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.93M | 32.20% |
| Dec 27, 2024 | 1.46M | -71.99% |
| Dec 29, 2023 | 5.20M | -38.11% |
| Dec 30, 2022 | 8.41M | -30.89% |
| Dec 31, 2021 | 12.17M | -65.63% |
| Jan 28, 2021 | 35.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |